Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...
Intensity Therapeutics, Inc. ("Intensity" or the "Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...
Drivers: Increasing focus on airport development, rising investment in smart airports. Restraints: Vulnerability to cybersecurity threats. Opportunities: Process and ...
GeneTether Therapeutics Inc. (CSE: GTTX) today announced that it has changed its name to Rize Oncology Inc. (“Rize” or the “Company”). This rebranding reflects the Company's strategic shift towards ...
Lu Wenna, an auxiliary police officer in southwestern China’s Yunnan province, passed away on December 6 from a rare form of cancer known as rhabdomyosarcoma, a type of soft tissue sarcoma.
Therefore, a new corpus sarcoma staging system was developed based on the criteria used in other soft tissue sarcomas. [2] This is described as a best guess staging system, so data will need to be ...